Anti-inflammatory action of geopropolis produced by stingless bees on human peripheral blood mononuclear cells

Hum Immunol. 2024 Jul;85(4):110825. doi: 10.1016/j.humimm.2024.110825. Epub 2024 May 24.

Abstract

Natural products have been used to treat inflammatory reactions and led to the discovery of new anti-inflammatory drugs. Geopropolis (GEO) is produced by stingless bees and has been used by indigenous people to improve the immune functions. Here, a possible synergism between GEO and dexamethasone (DEX) was assessed on human peripheral blood mononuclear cells (PBMC) stimulated by lipopolysaccharide (LPS). PBMC viability was evaluated by the MTT, apoptosis/necrosis by flow cytometry, cytokine and eicosanoids production by ELISA, and intracellular pathways by polymerase chain reaction. GEO and DEX alone or in combination did not affect cell viability. GEO in combination with lower concentrations of DEX inhibited cytokine production (TNF-α, IL-1β, and IL-10). No effects were seen on eicosanoids nor in intracellular pathways. Despite not always being more efficient than the isolated treatments, GEO + DEX seemed to be promising and allow the use of DEX in lower concentrations, reducing adverse effects.

Keywords: Geopropolis; Inflammation; Peripheral blood mononuclear cells; Stingless bees.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents* / pharmacology
  • Apoptosis / drug effects
  • Bees
  • Cell Survival / drug effects
  • Cells, Cultured
  • Cytokines / metabolism
  • Dexamethasone* / pharmacology
  • Drug Synergism
  • Humans
  • Leukocytes, Mononuclear* / drug effects
  • Leukocytes, Mononuclear* / immunology
  • Leukocytes, Mononuclear* / metabolism
  • Lipopolysaccharides* / pharmacology
  • Propolis* / pharmacology

Substances

  • Anti-Inflammatory Agents
  • Dexamethasone
  • Lipopolysaccharides
  • Propolis
  • Cytokines